Touchdown Ventures logo

Touchdown Ventures

North America, New Jersey, United States, Haddonfield

Description

Touchdown Ventures is a distinctive corporate venture capital firm established in 2014, operating with a unique model that sets it apart in the venture landscape. Rather than investing its own balance sheet, Touchdown co-founds and manages dedicated corporate venture capital funds on behalf of large, established corporations. This specialized approach allows corporations to strategically engage with the startup ecosystem, leveraging Touchdown's expertise in venture investing while aligning investments with their core business objectives. The firm maintains offices in key innovation hubs including Los Angeles, Philadelphia, and San Francisco, facilitating broad market access.

The firm's impressive roster of corporate partners underscores its credibility and reach. These partners span diverse industries and include household names such as Kellogg's, T-Mobile, USAA, SC Johnson, Ally Financial, and Fujifilm, among others. Touchdown Ventures acts as an outsourced CVC arm, handling all aspects of fund management from deal sourcing and due diligence to portfolio management and value creation. This enables its corporate clients to tap into new technologies and business models without building an in-house venture team from scratch, thereby mitigating risk and optimizing resource allocation.

Touchdown Ventures primarily focuses on early and growth-stage companies, with investment sectors dictated by the strategic interests of its corporate partners. This flexible mandate allows them to invest across a wide array of industries, from consumer goods and financial services to telecommunications and advanced materials. Their portfolio boasts investments in high-profile companies like Impossible Foods and Allbirds, demonstrating their capacity to identify and support disruptive innovators. The firm's value proposition extends beyond capital, aiming to foster synergistic relationships between startups and their corporate backers, facilitating commercial partnerships and strategic growth opportunities.

In terms of scale, Touchdown Ventures has demonstrated significant capacity, managing over $500 million in assets as of 2020 across its various corporate funds. This substantial capital base supports a robust investment pace, with the firm having made over 150 investments into promising companies. While specific check sizes can vary based on the corporate partner's strategic goals and the stage of the investment, Touchdown typically participates in rounds ranging from $1 million for early-stage, strategically aligned opportunities, up to $20 million for more mature growth-stage companies that offer significant strategic value to their corporate limited partners.

Investor Profile

Touchdown Ventures has backed more than 72 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 1% of its total and boasts 18 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Seed rounds (top funding stages).
  • Majority of deals are located in United States, Israel, Canada.
  • Strong thematic focus on Software, Artificial Intelligence (AI), Machine Learning.
  • Led 1 rounds in the past year.
  • Typical check size: $1M – $20M.

Stage Focus

  • Series B (25%)
  • Series A (21%)
  • Seed (18%)
  • Series C (13%)
  • Series Unknown (11%)
  • Series D (7%)
  • Series E (1%)
  • Corporate Round (1%)
  • Pre Seed (1%)
  • Debt Financing (1%)

Country Focus

  • United States (86%)
  • Israel (6%)
  • Canada (4%)
  • India (3%)
  • United Kingdom (1%)

Industry Focus

  • Software
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Health Care
  • Information Technology
  • Saas
  • Legal
  • Food And Beverage
  • Legal Tech
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Touchdown Ventures frequently co-invest with?

Tegna
North America, Virginia, United States, Mclean
Co-Investments: 3
Allegion Ventures
Europe, Dublin, Ireland, Dublin
Co-Investments: 8
Accomplice
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 3
S2G Ventures
North America, Illinois, United States, Chicago
Co-Investments: 4
Eighteen94 Capital
North America, Michigan, United States, Battle Creek
Co-Investments: 6
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 4
FirstMark
North America, New York, United States, New York
Co-Investments: 3
Avery Dennison
North America, California, United States, Glendale
Co-Investments: 5
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 4

Which angels does Touchdown Ventures often collaborate with?

David Blitzer
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 1
IM
North America, New York, United States, New York
Shared Deals: 1
CL
North America, Tennessee, United States, Nashville
Shared Deals: 1
SH
North America, California, United States, Los Angeles
Shared Deals: 1
CN
North America, California, United States, Los Angeles
Shared Deals: 1
Pankaj Gupta
Asia, Dubai, United Arab Emirates, Dubai
Shared Deals: 1
Sergio A. Escobar
North America, Quebec, Canada, Montréal
Shared Deals: 2
Cyriac Roeding
North America, California, United States, Portola Valley
Shared Deals: 1
Manisha Raisinghani
Asia, Maharashtra, India, Mumbai
Shared Deals: 1
KP
North America, Florida, United States, Miami
Shared Deals: 1

What are some of recent deals done by Touchdown Ventures?

Syntis Bio

Boston, Massachusetts, United States

Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.

Health CareMedicalTherapeutics
Series AJul 1, 2025
Amount Raised: $33,000,000
AmpUp

Santa Clara, California, United States

AmpUp is an electric vehicle charging company that enables drivers, hosts, and fleets to charge stress-free.

AutomotiveClean EnergyElectric VehicleFleet ManagementTransportation
Series ASep 26, 2024
Amount Raised: $15,000,000
Atropos Health

Palo Alto, California, United States

Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.

Clinical TrialsHealth CareInformation TechnologyMedical
Series BMay 23, 2024
Amount Raised: $33,000,000
Trust & Will

San Diego, California, United States

Trust & Will is the leading digital estate planning and probate platform.

FinTechInternetLegalWealth Management
Series UnknownJan 18, 2024
Valid8 Financial

Seattle, Washington, United States

Valid8 Financial offers financial services investigations by extracting and reconciling banking transactions from any PDF statement.

BankingFinanceFinancial ServicesFinTech
Series ANov 30, 2023
Amount Raised: $8,500,000
DetraPel

Framingham, Massachusetts, United States

DetraPel is a cleantech advanced materials company that specializes in synthesizing and manufacturing PFAS-Free Protective Coatings.

Consumer GoodsManufacturingNanotechnology
Series ASep 11, 2023
Amount Raised: $7,600,000
MEND

New York, New York, United States

MEND is a life sciences company that focuses on clinical nutrition and medical foods.

BiotechnologyHealth CareLife ScienceNutraceutical
Series AJun 6, 2023
Amount Raised: $15,000,000
Steno

Los Angeles, California, United States

Steno provides technology-enhanced court reporting and litigation services, including remote depositions and deferred payment solutions.

Document ManagementLegalLegal TechPayments
Series BMay 23, 2023
Amount Raised: $15,000,000
Syntis Bio

Milton, Massachusetts, United States

Syntis Bio operates as a late-stage preclinical company intended to develop a new class of therapy.

Health CareMedicalTherapeutics
SeedJan 17, 2023
Amount Raised: $15,372,179
Novome Biotechnologies

South San Francisco, California, United States

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

BiopharmaBiotechnologyTherapeutics
Series BSep 13, 2022
Amount Raised: $43,500,000